When Mark Cuban Cost Plus Drug Company Says Your Prescription is " Out of stock "

My followers may recall that about a year ago (on August 22, 2023), I blogged about (see https://blog.sstrumello.com/2022/08/generic-crestor-pricing-insanity.html for the post) that I had made a conscious decision to simply disintermediate my own insurance pharmacy benefit to buy an inexpensive generic statin drug because my own pharmacy benefit manager was screwing me. Currently, I ' m covered by Aetna which is now owned by CVS Health, which also owns the  PBM known as Caremark. Caremark was robbing me on the statin. It was overcharging me. They were trying to charge me $33.85 for a 90-day supply of a cheap generic drug which was made in India. USC researchers found that for almost one quarter of filled pharmacy prescriptions (23%) involved a patient copayment that exceeded the average reimbursement paid by the insurer (and their PBM) by more than $2.00. In other words, PBMs were screwing covered patients about one-quarter of the time (seehttps://healthpolicy.usc.edu/research/overpaying-for-prescription-drugs/ for the research). I knew I was being screwed, so I bypassed my insurance. It was easy. Until it wasn ' t easy any more.Initially, I bought the drug from Caremark ' s biggest rival: United Healthcare ' s OptumRx. But then United Healthcare sold its cash retail pharmacy business known as Optum Store to RVO Health LLC, which was also the entity which acquired the old DiabetesMine (at least indirectly, it owned what was known as Healthline, which previ...
Source: Scott's Web Log - Category: Endocrinology Tags: 2023 cash pharmacy cash-only pharmacy Crestor Mark Cuban Cost Plus Drug Company rosuvastatin calcium Source Type: blogs